A feasibility study of pulmonary rehabilitation at home in patients with lung cancer or malignant pleural mesothelioma treated by (radio-)chemotherapy Source: International Congress 2014 – Best abstracts in pulmonary rehabilitation and exercise training Year: 2014
A randomised trial of active symptom control (ASC) with or without chemotherapy (CT) in the treatment of patients with malignant pleural mesothelioma. First results of the Medical Research Council/British Thoracic Society MS01 trial Source: Annual Congress 2007 - Pleural malignancy Year: 2007
Belgian prospective, multicenter, observational study of patients with malignant pleural mesothelioma treated with pemetrexed plus platinum Source: International Congress 2014 – Diagnosis and treatment of pleural mesothelioma Year: 2014
Pleurectomy/decortication for malignant pleural mesothelioma: a single-centre experience. Source: Virtual Congress 2020 – Thoracic surgery: developments in diagnostics and outcomes Year: 2020
EUS-assisted lung disease evaluation – A Portuguese single centre 9-year experience Source: International Congress 2016 – The best clinical approach to lung diseases Year: 2016
Treatment and survival in patients with pulmonary carcinoid tumours; an updated analysis from the UK national lung cancer audit Source: International Congress 2015 – Thoracic oncology around the world: rare cases and local features Year: 2015
Follow -up results, malignancy rates and malignancy determinants of the pulmonary nodules that evaluated in multidisciplinary thoracic oncology tumour board Source: International Congress 2015 – Quality management in lung cancer Year: 2015
Impact of second-line treatment on overall survival of advanced lung adenocarcinoma patients Source: International Congress 2016 – Lung cancer: therapeutic modalities, re-staging, and follow-up Year: 2016
Retrospective review of a novel clinical service and pathway for patients with pulmonary nodules Source: International Congress 2016 – Quality management and quality of life in lung cancer Year: 2016
Influence of neoadjuvant therapy to complication rate after surgery for primary lung cancer Source: International Congress 2016 – Surgical strategy for complex diseases Year: 2016
Single-institution experience of surgical management of metastasises of colorectal cancer in lungs: Lessons learned Source: Annual Congress 2013 –Oncological thoracic surgery Year: 2013
Retrospective review of VATS (Pleural) negative biopsy and their outcome in a university hospital Source: International Congress 2016 – Mesothelioma and pleural disease: from the bench to the bedside Year: 2016
Population-based survival for malignant mesothelioma after introduction of novel chemotherapy Source: Eur Respir J 2012; 40: 185-189 Year: 2012
Mode of influence of the type of the chest wall invasion to the outcome of surgical treatment of patients with primary lung cancer Source: International Congress 2015 – Surgery and lung cancer: results and complications Year: 2015
Evaluation of outpatient infections in lung cancer patients treated with chemotherapy and/or radiotherapy Source: Annual Congress 2012 - Screening, diagnosis, staging and treatment strategies for lung cancer Year: 2012
Natural course of asymptomatic malignant pleural effusion in non-small-cell lung cancer patients: a multicenter retrospective study Source: Virtual Congress 2020 – Real-world data and registries of thoracic oncology Year: 2020
Determinants of survival in patients with malignant pleural mesothelioma (MPM) managed at a single institution in Liguria, Italy Source: International Congress 2018 – Clinical management of pleural malignancies, including mesothelioma Year: 2018
Characteristics of malignant pleural effusions. Review of one-year data from a large tertiary centre Source: Annual Congress 2013 –Diagnosis and management of pleural and mediastinal diseases Year: 2013
Is there equitable access to PET-CT for lung cancer patients across a large UK cancer network; a retrospective study of 4597 patients Source: International Congress 2015 – Quality management in lung cancer Year: 2015
Primary lung sarcomas and sarcomatoid carcinomas – Clinicopathological prognostic factors in operated patients Source: Annual Congress 2013 –Other thoracic tumours, particular circumstances and rare cases Year: 2013